Literature DB >> 17087121

Local anesthetics.

F Yanagidate1, G R Strichartz.   

Abstract

Local anesthetics are used broadly to prevent or reverse acute pain and treat symptoms of chronic pain. This chapter, on the analgesic aspects of local anesthetics, reviews their broad actions that affect many different molecular targets and disrupt their functions in pain processing. Application of local anesthetics to peripheral nerve primarily results in the blockade of propagating action potentials, through their inhibition of voltage-gated sodium channels. Such inhibition results from drug binding at a site in the channel's inner pore, accessible from the cytoplasmic opening. Binding of drug molecules to these channels depends on their conformation, with the drugs generally having a higher affinity for the open and inactivated channel states that are induced by membrane depolarization. As a result, the effective potency of these drugs for blocking impulses increases during high-frequency repetitive firing and also under slow depolarization, such as occurs at a region of nerve injury, which is often the locus for generation of abnormal, pain-related ectopic impulses. At distal and central terminals the inhibition of voltage-gated calcium channels by local anesthetics will suppress neurogenic inflammation and the release of neurotransmitters. Actions on receptors that contribute to nociceptive transduction, such as TRPV1 and the bradykinin B2 receptor, provide an independent mode of analgesia. In the spinal cord, where local anesthetics are present during epidural or intrathecal anesthesia, inhibition of inotropic receptors, such as those for glutamate, by local anesthetics further interferes with neuronal transmission. Activation of spinal cord mitogen-activated protein (MAP) kinases, which are essential for the hyperalgesia following injury or incision and occur in both neurons and glia, is inhibited by spinal local anesthetics. Many G protein-coupled receptors are susceptible to local anesthetics, with particular sensitivity of those coupled via the Gq alpha-subunit. Local anesthetics are also infused intravenously to yield plasma concentrations far below those that block normal action potentials, yet that are frequently effective at reversing neuropathic pain. Thus, local anesthetics modify a variety of neuronal membrane channels and receptors, leading to what is probably a synergistic mixture of analgesic mechanisms to achieve effective clinical analgesia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17087121     DOI: 10.1007/978-3-540-33823-9_4

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  15 in total

1.  Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels.

Authors:  Ken McCormack; Sonia Santos; Mark L Chapman; Douglas S Krafte; Brian E Marron; Christopher W West; Michael J Krambis; Brett M Antonio; Shannon G Zellmer; David Printzenhoff; Karen M Padilla; Zhixin Lin; P Kay Wagoner; Nigel A Swain; Paul A Stupple; Marcel de Groot; Richard P Butt; Neil A Castle
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

Review 2.  Platelet-rich plasma and the elimination of neuropathic pain.

Authors:  Damien P Kuffler
Journal:  Mol Neurobiol       Date:  2013-07-07       Impact factor: 5.590

3.  Bioadhesive films containing benzocaine: correlation between in vitro permeation and in vivo local anesthetic effect.

Authors:  Daniele Ribeiro de Araujo; Cristina Padula; Cíntia Maria Saia Cereda; Giovana Radomille Tófoli; Rui Barbosa Brito; Eneida de Paula; Sara Nicoli; Patrizia Santi
Journal:  Pharm Res       Date:  2010-04-28       Impact factor: 4.200

Review 4.  Current and Future Issues in the Development of Spinal Agents for the Management of Pain.

Authors:  Tony L Yaksh; Casey J Fisher; Tyler M Hockman; Ashley J Wiese
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 5.  Inhibition of NaV1.7: the possibility of ideal analgesics.

Authors:  Yutaka Kitano; Tsuyoshi Shinozuka
Journal:  RSC Med Chem       Date:  2022-08-01

6.  Lidocaine prevents referred hyperalgesia associated with cystitis.

Authors:  Simone D Guerios; Zun-Yi Wang; Kyle Boldon; Wade Bushman; Dale E Bjorling
Journal:  Neurourol Urodyn       Date:  2009       Impact factor: 2.696

Review 7.  MAP kinase and pain.

Authors:  Ru-Rong Ji; Robert W Gereau; Marzia Malcangio; Gary R Strichartz
Journal:  Brain Res Rev       Date:  2008-12-25

8.  Local Anesthetic Effect of Amitriptyline versus Lidocaine in Isolated Lesion of the Limb Requiring Primary Suturing; Assessing a Novel Therapeutic Agent.

Authors:  Rasoul Salimi; Rasool Haddadi; Abbas Moradi; Farnoush Jalilvand; Farzin Firozian
Journal:  Bull Emerg Trauma       Date:  2019-07

Review 9.  Interaction of local anesthetics with biomembranes consisting of phospholipids and cholesterol: mechanistic and clinical implications for anesthetic and cardiotoxic effects.

Authors:  Hironori Tsuchiya; Maki Mizogami
Journal:  Anesthesiol Res Pract       Date:  2013-09-23

10.  Electroencephalographic changes associated with antinociceptive actions of lidocaine, ketamine, meloxicam, and morphine administration in minimally anaesthetized dogs.

Authors:  Ubedullah Kaka; Chen Hui Cheng; Goh Yong Meng; Sharida Fakurazi; Asmatullah Kaka; Atique Ahmed Behan; Mahdi Ebrahimi
Journal:  Biomed Res Int       Date:  2015-01-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.